↓ Skip to main content

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma

Overview of attention for article published in CTS: Clinical & Translational Science, May 2021
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma
Published in
CTS: Clinical & Translational Science, May 2021
DOI 10.1111/cts.13029
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 4 11%
Student > Bachelor 3 8%
Other 2 5%
Student > Doctoral Student 2 5%
Student > Master 2 5%
Other 4 11%
Unknown 21 55%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 10 26%
Biochemistry, Genetics and Molecular Biology 1 3%
Business, Management and Accounting 1 3%
Nursing and Health Professions 1 3%
Neuroscience 1 3%
Other 1 3%
Unknown 23 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2021.
All research outputs
#27,765,906
of 34,412,533 outputs
Outputs from CTS: Clinical & Translational Science
#1,043
of 1,420 outputs
Outputs of similar age
#362,374
of 485,940 outputs
Outputs of similar age from CTS: Clinical & Translational Science
#43
of 61 outputs
Altmetric has tracked 34,412,533 research outputs across all sources so far. This one is in the 16th percentile – i.e., 16% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,420 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 485,940 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.